HIV and hepatitis B and C in Latvia
At the request of the Ministry of Health in Riga, a team of experts from ECDC and the European Monitoring Centre for Drugs and Drug Addiction paid a technical visit to Latvia on 2–4 September 2014. The aim of the joint mission was to analyse the epidemiological situation, review current prevention and control efforts, and propose key actions for strengthening the response to HIV and hepatitis B and C. The mission confirmed the very high rate of infections with hepatitis B and C, HIV, and AIDS, concentrated mainly among certain populations at higher risk. Based on the findings of this mission, the mission team prepared a comprehensive list of remedial actions.
HIV Pre-Exposure Prophylaxis in the EU/EEA and the UK: implementation, standards and monitoring
5 Mar 2021 - This operational guidance document provides practical recommendations and key considerations to inform the development and implementation of PrEP programmes at national and sub-national levels throughout the EU/EEA.
Guidance on HPV vaccination in EU countries: focus on boys, people living with HIV and 9-valent HPV vaccine introduction
30 Mar 2020 - This document summarises evidence from studies included in the licensing file of HPV vaccines together with postlicensure, peer-reviewed data and analysis where available. This guidance does not address the safety of HPV vaccines observed during the pre- and post-licensing period.
Toolkit to support the generation of robust estimates of hepatitis C prevalence
5 Mar 2020 - European surveillance data show on-going transmission of viral hepatitis across the European Union and European Economic Area (EU/EEA). The available notification data however, do not provide a clear epidemiological picture of hepatitis C in Europe. Prevalence data from population surveys are a key source of information to complement the surveillance data for hepatitis C due to the limitations of surveillance for hepatitis: the infection is often asymptomatic and notifications are strongly influenced by local testing practices. The overarching aim of this toolkit is to gain a better understanding of the HCV epidemiology in the EU/EEA.